TBK1, an abbreviation for TANK-binding kinase 1, is a serine/threonine-protein kinase that plays an integral role in various signaling pathways, especially those involved in immune response and cellular homeostasis. This kinase is a member of the IκB kinase (IKK) family, which primarily focuses on activating the NF-κB pathway, a pivotal pathway in controlling immune responses. TBK1, in particular, is known to get involved in the type I interferon production pathway. Interferons are proteins that our cells produce in response to viruses, aiming to hinder viral replication and spread. By activating TBK1, one can potentially modulate and amplify these inherent cellular defense mechanisms.
Chemically, TBK1 activators are a group of compounds that can augment the kinase activity of TBK1. These molecules, either natural or synthetic, interact with TBK1 in a way that enhances its kinase function, thereby leading to an upregulated downstream signaling. The mode of action by which these activators work can vary. Some might bind directly to the kinase domain of TBK1, causing a conformational change that boosts its activity. Others might bind to a separate domain or an associated protein, altering its interaction dynamics and indirectly promoting its kinase activity. A precise understanding of the structural biology and molecular mechanisms of action for each activator is crucial for predicting its effects on TBK1 and its downstream pathways. While the research field surrounding TBK1 activators is expanding, the quest for novel compounds and a deeper understanding of their interactions remains ongoing.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Polyinosinic acid - polycytidylic acid sodium salt, double-stranded | 42424-50-0 | sc-204854 sc-204854A | 10 mg 100 mg | $139.00 $663.00 | 2 | |
Poly(I:C) mimics double-stranded RNA, a product of viral replication. This can lead to TBK1 activation as part of the host defense mechanism against viruses. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol, a compound found in red wine, has been shown to activate TBK1. The exact mechanism is not fully understood but may be related to its anti-inflammatory properties. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin, a component of turmeric, has been reported to enhance TBK1 activity. This might be due to its role in modulating inflammatory responses. | ||||||
Imiquimod | 99011-02-6 | sc-200385 sc-200385A | 100 mg 500 mg | $67.00 $284.00 | 6 | |
Imiquimod is a toll-like receptor 7 (TLR7) agonist, leading to activation of TBK1 and downstream interferon responses. | ||||||
Ruxolitinib | 941678-49-5 | sc-364729 sc-364729A sc-364729A-CW | 5 mg 25 mg 25 mg | $251.00 $500.00 $547.00 | 16 | |
Although primarily known as a JAK inhibitor, ruxolitinib has been shown to modulate TBK1 activity under certain conditions. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
BAY 11-7082 inhibits NF-κB activation and has been shown to influence TBK1 expression in certain studies. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
Etoposide, a DNA topoisomerase inhibitor, can activate the DNA damage response, which may lead to indirect TBK1 activation. | ||||||
Oxaliplatin | 61825-94-3 | sc-202270 sc-202270A | 5 mg 25 mg | $112.00 $394.00 | 8 | |
Oxaliplatin induces DNA damage, which can potentially lead to an increased expression of TBK1 as part of the cellular response to such damage. | ||||||
2′,3′-cGAMP | 1441190-66-4 | sc-507484 | 10 mg | $1800.00 | ||
This cyclic dinucleotide activates the STING pathway, leading to TBK1 activation and type I interferon responses. | ||||||